Advertisement
Research Article Free access | 10.1172/JCI119635
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA.
Find articles by Zheng, Z. in: JCI | PubMed | Google Scholar
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA.
Find articles by Cummings, R. in: JCI | PubMed | Google Scholar
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA.
Find articles by Pummill, P. in: JCI | PubMed | Google Scholar
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA.
Find articles by Kincade, P. in: JCI | PubMed | Google Scholar
Published September 1, 1997 - More info
The density, molecular isoform, and posttranslational modifications of CD44 can markedly influence growth and metastatic behavior of tumors. Many CD44 functions, including some involving tumors, have been attributed to its ability to recognize hyaluronan (HA). However, only certain CD44-bearing cells bind soluble or immobilized HA. We now show that CD44 made by wild-type Chinese hamster ovary (CHO-K1) cells and a ligand-binding subclone differ with respect to N-linked glycosylation. While both bear CD44 with highly branched, complex-type glycoforms, CD44 expressed by the wild type was more extensively sialylated. CHO-K1 cells which failed to recognize HA when grown in culture gained this ability when grown as a solid tumor and reverted to a non-HA-binding state when returned to culture. The ability of CHO-K1 cells to recognize HA was also reversibly induced when glucose concentrations in the medium were reduced. Glucose restriction influenced CD44-mediated HA binding by many but not all, of a series of murine tumors. Glucose concentrations and glycosylation inhibitors only partially influenced CD44 receptor function on resting murine B lymphocytes. These observations suggest that glucose levels or other local environmental conditions may markedly influence glycosylation pathways used by some tumor cells, resulting in dramatic alteration of CD44-mediated functions.